MINNEAPOLIS, Jan. 05, 2022 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE:INSP) ("Inspire"), a medical technology company focused on the development and commercialization of innovative and minimally invasive solutions for patients with obstructive sleep apnea, today announced that it will release financial results for the fourth quarter and year ended December 31, 2021 after the close of trading on Tuesday, February 8. Inspire's management team will host a corresponding conference call beginning at 5:00 p.m. Eastern Time to discuss the financial results and recent business developments.

*Tuesday, February 8*^th @ 5:00 p.m. Eastern Time:
Domestic:	(800) 344-0786
International:	(209) 905-5969
Conference ID:	6196895
Webcast:	https://edge.media-server.com/mmc/p/yqez27hd

About Inspire Medical Systems

Inspire is a medical technology company focused on the development and commercialization of innovative and minimally invasive solutions for patients with obstructive sleep apnea. Inspire's proprietary Inspire therapy is the first and only FDA-approved neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea.

For additional information about Inspire, please visit www.inspiresleep.com.

Investor and Media Contact:

Bob Yedid

LifeSci Advisors

inspire@lifesciadvisors.com

646-597-6989

Inspire Medical Systems, Inc. to Report Fourth Quarter and Fiscal 2021 Financial Results on February 8, 2022